# BLYS and IFN in SLE

> **NCT00611611** · — · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 39 (actual)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **BIOLOGICAL:** fluzone
- **BIOLOGICAL:** pneumovax

## Key facts

- **NCT ID:** NCT00611611
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2011-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00611611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00611611, "BLYS and IFN in SLE". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00611611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*